UCB S.A. UNSP.ADR 1/2 Asset Resilience Ratio

Latest as of June 2026: 2.05%

UCB S.A. UNSP.ADR 1/2 asset resilience ratio. UCB S.A. UNSP.ADR 1/2 (UNC0) has an Asset Resilience Ratio of 2.05% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read UCB S.A. UNSP.ADR 1/2 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€422.00 Million
≈ $493.36 Million USD Cash + Short-term Investments

Total Assets

€20.63 Billion
≈ $24.12 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of UCB S.A. UNSP.ADR 1/2 (2021–2025)

Asset resilience ratio of UCB S.A. UNSP.ADR 1/2 from 2021 to 2025. This chart shows how UCB S.A. UNSP.ADR 1/2's Asset Resilience Ratio has changed over time. See UCB S.A. UNSP.ADR 1/2 (UNC0) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down UCB S.A. UNSP.ADR 1/2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see UNC0 total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €422.00 Million 2.05%
Total Liquid Assets €422.00 Million 2.05%

Asset Resilience Insights

  • Limited Liquidity: UCB S.A. UNSP.ADR 1/2 maintains only 2.05% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

UCB S.A. UNSP.ADR 1/2 Industry Peers by Asset Resilience Ratio

Compare UCB S.A. UNSP.ADR 1/2's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
HLB Co. Ltd
KQ:028300
Biotechnology 3.29%
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Shanghai Medicilon Inc
SHG:688202
Biotechnology 6.69%
Blue Jet Healthcare Limited
NSE:BLUEJET
Biotechnology 13.81%
Hangzhou Biotest Biotech Co Ltd
SHG:688767
Biotechnology 0.56%
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
Biotechnology 79.76%
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
Biotechnology 5.52%

UCB S.A. UNSP.ADR 1/2 Asset Resilience Ratio by Year (2021–2025)

UCB S.A. UNSP.ADR 1/2 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for UCB S.A. UNSP.ADR 1/2.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.08% €196.00 Million
≈ $229.14 Million
€18.16 Billion
≈ $21.23 Billion
+0.02pp
2024-12-31 1.06% €184.00 Million
≈ $215.12 Million
€17.35 Billion
≈ $20.28 Billion
-0.19pp
2023-12-31 1.25% €195.00 Million
≈ $227.98 Million
€15.54 Billion
≈ $18.17 Billion
-0.28pp
2022-12-31 1.53% €243.00 Million
≈ $284.09 Million
€15.87 Billion
≈ $18.55 Billion
+0.04pp
2021-12-31 1.49% €212.00 Million
≈ $247.85 Million
€14.21 Billion
≈ $16.61 Billion
--
pp = percentage points

About UCB S.A. UNSP.ADR 1/2

F:UNC0 Germany Biotechnology
Market Cap
$53.31 Billion
€45.60 Billion EUR
Market Cap Rank
#599 Global
#124 in Germany
Share Price
€120.00
Change (1 day)
-2.44%
52-Week Range
€71.50 - €142.00
All Time High
€142.00
About

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF-mediated diseases, as well as ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthr… Read more